Antiarrhythmic Drugs Market Size, Share, Trends, Forecast 2033

The antiarrhythmic drugs market is the industry that develops, produces, and sells medications to treat irregular heart rhythms, including oral and intravenous drugs, for various applications including hospitals and clinics. Antiarrhythmic agents like digoxin, quinidine, and procainamide are safe and effective in treating symptomatic patients with life-threatening arrhythmias during pregnancy as first-line therapy. The market growth is fueled by factors such as the increasing prevalence of cardiovascular diseases, drug development innovations, and supportive regulatory frameworks. T